Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
1995 1
1998 1
1999 1
2000 1
2001 1
2004 4
2005 3
2006 1
2008 3
2009 2
2010 2
2011 1
2012 2
2013 3
2014 1
2015 2
2016 1
2017 3
2018 1
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Skin Angiosarcoma"
Page 1
Angiosarcoma: clinical and imaging features from head to toe.
Gaballah AH, Jensen CT, Palmquist S, Pickhardt PJ, Duran A, Broering G, Elsayes KM. Gaballah AH, et al. Br J Radiol. 2017 Jul;90(1075):20170039. doi: 10.1259/bjr.20170039. Epub 2017 May 4. Br J Radiol. 2017. PMID: 28471264 Free PMC article. Review.
Angiosarcoma is a rare, aggressive subtype of soft-tissue sarcoma with a propensity for local recurrence and metastasis associated with a generally poor prognosis, unless diagnosed early. Given the vascular endothelial cell origin of angiosarcoma, tumours may
Angiosarcoma is a rare, aggressive subtype of soft-tissue sarcoma with a propensity for local recurrence and metastasis associ
c-myc and cutaneous vascular neoplasms.
Feller JK, Mahalingam M. Feller JK, et al. Am J Dermatopathol. 2013 May;35(3):364-9. doi: 10.1097/DAD.0b013e31827aad83. Am J Dermatopathol. 2013. PMID: 23221487 Review.
This gives c-myc a dual oncogenic function in that tumor growth requires both cell proliferation and angiogenesis to ensure survival and confer an effective malignancy. Amplification of c-myc has been recently reported to be a recurrent genetic alteration in angiosarcom
This gives c-myc a dual oncogenic function in that tumor growth requires both cell proliferation and angiogenesis to ensure survival and con …
Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
Buffo TH, Stelini RF, Serrano JYM, Pontes LT, Magalhães RF, de Moraes AM. Buffo TH, et al. An Bras Dermatol. 2023 Jan-Feb;98(1):36-46. doi: 10.1016/j.abd.2022.01.009. Epub 2022 Nov 8. An Bras Dermatol. 2023. PMID: 36369200 Free PMC article.
METHODS: This was a retrospective observational study including rare skin tumors and less common variants of basal cell carcinoma and squamous cell carcinoma treated using Mohs micrographic surgery, between October 2008 and April 2021. ...CONCLUSION: This retrospect …
METHODS: This was a retrospective observational study including rare skin tumors and less common variants of basal cell carcin …
Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients.
Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, Fujita J, Uezato H, Murayama S. Ogawa K, et al. Br J Radiol. 2012 Nov;85(1019):e1127-33. doi: 10.1259/bjr/31655219. Epub 2012 Jul 17. Br J Radiol. 2012. PMID: 22806620 Free PMC article.
RESULTS: At the time of analysis, 45 of 48 patients (93.8%) had disease recurrences, and the lung was the most frequent site for recurrence (37 patients). ...Advances in knowledge Multimodal treatments including surgery and radiotherapy are effective in improving ov …
RESULTS: At the time of analysis, 45 of 48 patients (93.8%) had disease recurrences, and the lung was the most frequent site for r
Angiosarcoma of the scalp and face: the Mayo Clinic experience.
Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ, Halyard MY. Patel SH, et al. JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 25634014
OBJECTIVE: To determine the treatment outcomes of patients with angiosarcoma of the face or scalp treated with a combination of surgery, radiation therapy, and/or chemotherapy. ...INTERVENTIONS: Surgery, radiation therapy, and/or chemotherapy. MAIN OUTCOMES AND MEASURES: L …
OBJECTIVE: To determine the treatment outcomes of patients with angiosarcoma of the face or scalp treated with a combination of surge …
Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile.
Donghi D, Kerl K, Dummer R, Schoenewolf N, Cozzio A. Donghi D, et al. J Eur Acad Dermatol Venereol. 2010 Oct;24(10):1230-4. doi: 10.1111/j.1468-3083.2010.03624.x. J Eur Acad Dermatol Venereol. 2010. PMID: 20236193
BACKGROUND: Cutaneous angiosarcoma (AS) is a rare malignant tumour of endothelial origin with very poor prognosis, frequent recurrences and high metastatic potential. ...Radiotherapy was the most prescribed treatment, but many different combinations of surgery, chem …
BACKGROUND: Cutaneous angiosarcoma (AS) is a rare malignant tumour of endothelial origin with very poor prognosis, frequent recurr
Angiosarcoma: a tissue microarray study with diagnostic implications.
Rao P, Lahat G, Arnold C, Gavino AC, Lahat S, Hornick JL, Lev D, Lazar AJ. Rao P, et al. Am J Dermatopathol. 2013 Jun;35(4):432-7. doi: 10.1097/DAD.0b013e318271295a. Am J Dermatopathol. 2013. PMID: 23689692
BACKGROUND: Angiosarcoma (AS) is a rare soft tissue sarcoma showing endothelial differentiation as indicated by morphology and expression of CD31 (blood), D2-40 (lymphatic), factor VIII, and CD34 (both). ...Primary sites for the tumor included bone (n = 1), breast parenchy …
BACKGROUND: Angiosarcoma (AS) is a rare soft tissue sarcoma showing endothelial differentiation as indicated by morphology and expres …
Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors.
Willers H, Hug EB, Spiro IJ, Efird JT, Rosenberg AE, Wang CC. Willers H, et al. Int J Radiat Oncol Biol Phys. 1995 Oct 15;33(3):585-93. doi: 10.1016/0360-3016(95)00256-X. Int J Radiat Oncol Biol Phys. 1995. PMID: 7558947 Review.

For this group of patients, significant prognostic factors identified by uni- and multivariate analysis included tumor grade as a predictor of OS and T-stage as a predictor of LRC (p < or = 0.050). Those patients who experienced a locoregional recurrence w

For this group of patients, significant prognostic factors identified by uni- and multivariate analysis included tumor grade as a predict
Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature.
Adem C, Reynolds C, Ingle JN, Nascimento AG. Adem C, et al. Br J Cancer. 2004 Jul 19;91(2):237-41. doi: 10.1038/sj.bjc.6601920. Br J Cancer. 2004. PMID: 15187996 Free PMC article. Review.
Tumour size ranged from 0.3 to 12 cm (mean 5.7). Low-grade lesions were observed in 10 cases and high-grade in 15. Overall, mean follow-up was 10.5 years. Local recurrence was observed in 11 patients and ranged from 2 to 36 months (mean 15 m), while distant m …
Tumour size ranged from 0.3 to 12 cm (mean 5.7). Low-grade lesions were observed in 10 cases and high-grade in 15. Overall, mean foll …
Spectrum of malignant scalp tumours and its impact on management-a tertiary care cancer centre experience.
Varghese BT, Nadarajan AR, Thomas S, Iype EM, George NA, K M JK, Lal SS, Somanathan T. Varghese BT, et al. World J Surg Oncol. 2023 Oct 17;21(1):330. doi: 10.1186/s12957-023-03200-9. World J Surg Oncol. 2023. PMID: 37845728 Free PMC article.
In addition to this, 21% were sarcomas, 17% were appendageal carcinomas, 11% were BCCs, and 1% was neuroendocrine carcinoma. Cortical erosion was observed in 6 patients in the CT imaging, all with SCC histology. Among the eight patients with pathological nodal involvement, …
In addition to this, 21% were sarcomas, 17% were appendageal carcinomas, 11% were BCCs, and 1% was neuroendocrine carcinoma. Cortical erosio …
40 results